IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 21 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $975 | -38.2% | 533 | 0.0% | 0.00% | – |
| Q2 2023 | $1,578 | +6.9% | 533 | 0.0% | 0.00% | – |
| Q1 2023 | $1,476 | -46.8% | 533 | 0.0% | 0.00% | – |
| Q4 2022 | $2,777 | +38.8% | 533 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -66.7% | 533 | -67.4% | 0.00% | – |
| Q2 2022 | $6,000 | -70.0% | 1,633 | -57.5% | 0.00% | – |
| Q1 2022 | $20,000 | -4.8% | 3,843 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -12.5% | 3,843 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | +33.3% | 3,843 | +20.3% | 0.00% | – |
| Q2 2021 | $18,000 | -92.2% | 3,195 | -86.5% | 0.00% | – |
| Q1 2021 | $232,000 | +648.4% | 23,660 | +1026.7% | 0.00% | – |
| Q4 2020 | $31,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
| Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
| Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
| Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
| IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 7 | $0 | 0.00% |
| MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |